Munich-based digital health company Temedica and healthcare company Roche Pharma AG have announced a joint collaboration in the field of digital support for multiple sclerosis patients. The app - named Brisa - strives to help as many of the approximately 240,000 people affected by MS in Germany as possible by actively shaping their everyday lives, making a record of individual progression of the disease, and providing constant new incentives for motivation. Accordingly, Brisa’s motto is "Your tailwind for an independent life with MS".
The aim of the app developed by Temedica is to improve the care of MS patients according to the latest medical and technological standards. Brisa is designed as an individual digital companion for people with MS and supports them, regardless of their treatment, in measuring their personal disease progression and actively recognizing changes. Brisa is free of charge for users, and is intended to strengthen their health literacy and motivation to change their lifestyle in the long term.
"Today, digital technologies enable us to accelerate medical progress and together establish healthcare that focuses even more on the individual needs of patients," says Dr Carola Bruns, Medical Lead Neuroscience at Roche Pharma AG. "We are delighted that we have found an innovative partner for this in Temedica. We are convinced that together - and in cooperation with patients, treatment providers and scientists - we will make a valuable contribution to further deepen our understanding of MS and to further improve the quality of life of MS patients."
Gloria Seibert, founder and CEO of Temedica, stated "in line with our company vision of crafting the future of personal health, our digital patient companions are always designed with the patient and their individual needs in mind. Together with Roche, we want to improve the quality of life for people with MS and advance research into the disease - that's why we design accessibility and patient guidance to be as intuitive as possible, so that users enjoy using our apps regularly and receive real added value in the long term. Brisa has the potential to reach a large number of people with MS and support them individually throughout the course of their daily lives.”
Temedica has developed Brisa in cooperation with Roche to empower MS patients to take control of and manage their own health through continuous information and support. The app combines scientific expertise and digital technology and is a unique tool for people with MS to help them improve their quality of life."
Gloria Seibert, Founder and CEO, Temedica
Brisa's features include symptom tracking, individualized health data collection - such as activity levels, sleep patterns and dietary habits - and personalized therapy support with individualized recommendations based on the analysis of the recorded data.
$1 million grant supports research on groundbreaking therapies for MS